Gamstek

Founded in 2024 and based in Anhui, China, Gamstek is dedicated to the research and production of high-end mass spectrometry instruments and has executed 1 deal as of August 5, 2025. The founder's background includes previous ventures, contributing to their expertise in this field. In August 2025, Gamstek raised Angel funding from new investors Wofo Capital and Shenzhen Qiyu Investment Co. , Ltd.

Gamstek specializes in the research, development, manufacturing, and sales of high-end mass spectrometry instruments, including their flagship MS8000 ultra-efficient triple quadrupole LC-MS system. Their products meet international standards and serve sectors like material science, environmental monitoring, food safety testing, and biomedicine, primarily targeting clients in the Asia-Pacific region such as research institutions and pharmaceutical companies. Gamstek generates revenue through direct sales of mass spectrometry instruments and associated technical services on a B2B basis. Clients benefit from ongoing support, including on-site assistance and 24/7 customer service, reflecting the significant investment in high-end technology.